The Role of MicroRNAs in Vitiligo: Regulators and Therapeutic Targets
Related Experiment Video
Updated: Nov 7, 2025

Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Published on: August 27, 2021
1Department of Dermatology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Abstract:
Vitiligo is an acquired skin disorder clinically characterized by the progressive appearance of white maculae due to a loss of functioning epidermal melanocytes. Studies have shown that microRNAs (miRNAs) modulate cellular differentiation, proliferation and apoptosis, including immune cell and melanocyte development and functions. The role of miRNAs in the pathogenesis of several immune-related diseases has been explored. Novel approaches to target miRNAs have recently emerged allowing modulation of miRNAs levels in diverse pathological processes, thus making them promising targets for molecular-based diagnostics and therapy. Here, we report the present status of research on miRNAs expression and functional alterations in vitiligo, in order to more fully understand the role of these molecules in vitiligo pathology.
Related Concept Videos
MicroRNAs
MicroRNAs
Microorganisms in Medicine and Therapeutics
iPS Cell Differentiation
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Abnormal Proliferation

